DirkJan Hijnen

25PUBLICATIONS
94CO-AUTHORS
Epidemiological modellingDisease surveillancePharmacogenomicsSpecial needs dentistryAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Nov 17, 2025
Successful Dose Reduction of Janus-kinase Inhibitors in Well-controlled Atopic Dermatitis: A Prospective, Multicentre, Real-world Study.

Anne R Schlösser, Anouk G M Caron, Merle S Den Ouden

|Aug 20, 2025
Baseline characteristics of atopic eczema patients enrolled in seven European registries united in the TREatment of ATopic eczema (TREAT) registry taskforce.

A H Musters, L A A Gerbens, L van der Gang

|Mar 10, 2025
Long-term Outcomes of New Systemic Agents in Atopic Dermatitis: Drug Survival Analyses and Treatment Patterns in Daily Practice.

Anne R Schlosser, Lars Nijman, Renske Schappin

|Aug 05, 2024
Navigating the evolving landscape of atopic dermatitis: Challenges and future opportunities: The 4th Davos declaration.

Claudia Traidl-Hoffmann, Jamie Afghani, Cezmi A Akdis

|Mar 26, 2024
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2).

Jonathan I Silverberg, Melinda J Gooderham, Amy S Paller

|Mar 05, 2024
Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after mRNA vaccination.

Anika M Valk, Jim B D Keijser, Koos P J van Dam

Pageof 5

Frequent Collaborators

11 joint publications

Tamar Nijsten

8 joint publications

Linde E M de Wijs

5 joint publications

Jill Olydam

4 joint publications

Jonathan I Silverberg